4.7 Article

Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial

Thomas Powles et al.

Summary: In a recent study of advanced urothelial cancer patients, avelumab in combination with best supportive care significantly prolonged overall survival compared to care alone, with factors such as PD-L1 expression, tumor mutational burden, immune activity genes, and Fcγ receptor variants being positively associated with survival benefit. Individual biomarkers alone were not sufficient to predict therapy response, but multi-parameter models integrating genomic alterations, immune responses, and tumor growth showed potential for predictive utility. These findings highlight the complexity of biological pathways in immune checkpoint inhibition therapy and suggest the need for multiple biomarkers to identify patients who would benefit from treatment.

NATURE MEDICINE (2021)

Article Oncology

Role of NRP1 in Bladder Cancer Pathogenesis and Progression

Yang Dong et al.

Summary: Bladder urothelial carcinoma (BC) is a deadly malignancy, and Neuropilin-1 (NRP1) has been found to be highly expressed in BC tissues and cells. Knockdown of NRP1 promotes apoptosis and inhibits proliferation, angiogenesis, migration, and invasion of BC cells, potentially serving as a new therapeutic target for BC treatment. Additionally, NRP1 affects various biological functions through MAPK signaling and cancer pathways.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Advances in bladder cancer biology and therapy

Linda Tran et al.

Summary: Recent developments in bladder cancer research have focused on identifying mutated genes, understanding cellular aspects, and advancing non-invasive diagnostic methods. Immune checkpoint inhibitor therapeutics have shown significant therapeutic impact, providing patients with better monitoring options and hope for prolonged survival.

NATURE REVIEWS CANCER (2021)

Review Oncology

The rediscovery of platinum-based cancer therapy

Sven Rottenberg et al.

Summary: Platinum chemotherapy agents continue to be widely used in cancer treatment, with recent insights into DNA repair mechanisms providing valuable explanations for their success. The understanding of defective DNA repair in many cancers sheds new light on secondary drug resistance mechanisms.

NATURE REVIEWS CANCER (2021)

Article Urology & Nephrology

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

Aurelie Kamoun et al.

EUROPEAN UROLOGY (2020)

Article Oncology

Treatment of muscle-invasive and advanced bladder cancer in 2020

Vaibhav G. Patel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Oncology

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

Christopher A. Chuckran et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Review Medicine, General & Internal

Bladder Cancer: A Review

Andrew T. Lenis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Oncology

Discovery through clinical sequencing in oncology

Mark T. A. Donoghue et al.

NATURE CANCER (2020)

Article Biotechnology & Applied Microbiology

Determining cell type abundance and expression from bulk tissues with digital cytometry

Aaron M. Newman et al.

NATURE BIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1

Marine Leclerc et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Treatment resistance in urothelial carcinoma: an evolutionary perspective

Panagiotis J. Vlachostergios et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Review Oncology

The immune contexture in cancer prognosis and treatment

Wolf H. Fridman et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Medicine, General & Internal

Bladder cancer

Oner Sanli et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

Article Multidisciplinary Sciences

Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch et al.

NATURE (2015)

Article Medicine, Research & Experimental

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk

Agnieszka Dejda et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

Completion of the entire hepatitis C virus life cycle in genetically humanized mice

Marcus Dorner et al.

NATURE (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Gastroenterology & Hepatology

Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling

Mathieu Berge et al.

JOURNAL OF HEPATOLOGY (2011)